Treatment of peripheral leukopenia after cadaveric kidney transplantation.
Xiwen
B
B
Department of Kidney Transplantation, Nan Fang Hospital, First Military Medical College, Guang Zhou, China.
Lixin
Y
Y
Junjie
M
M
D000225:Adenine / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000009:adverse effects; D001803:Blood Transfusion; D002102:Cadaver; D004359:Drug Therapy, Combination; D005260:Female; D005995:Glyceryl Ethers / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D017708:Leukocyte Transfusion; D007970:Leukopenia / Q000209:etiology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D013844:Thiazoles / Q000627:therapeutic use; D053778:Thiazolidines; D014019:Tissue Donors
D005995:Glyceryl Ethers; D007166:Immunosuppressive Agents; D013844:Thiazoles; D053778:Thiazolidines; C001176:Leyk; C033433:batyl alcohol; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D000225:Adenine; D001379:Azathioprine